You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Parenteral glutamine supplementation in critical illness: a systematic review
|
|---|---|
| Published in |
Critical Care, April 2014
|
| DOI | 10.1186/cc13836 |
| Pubmed ID | |
| Authors |
Paul E Wischmeyer, Rupinder Dhaliwal, Michele McCall, Thomas R Ziegler, Daren K Heyland |
| Abstract |
The potential benefit of parenteral glutamine (GLN) supplementation has been one of the most commonly studied nutritional interventions in the critical care setting. The aim of this systematic review was to incorporate recent trials of traditional parenteral GLN supplementation in critical illness with previously existing data. |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | 24% |
| Spain | 3 | 14% |
| Australia | 2 | 10% |
| Italy | 1 | 5% |
| United States | 1 | 5% |
| Unknown | 9 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 48% |
| Scientists | 5 | 24% |
| Practitioners (doctors, other healthcare professionals) | 4 | 19% |
| Science communicators (journalists, bloggers, editors) | 2 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| South Africa | 1 | <1% |
| Saudi Arabia | 1 | <1% |
| Romania | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 167 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 28 | 16% |
| Student > Master | 23 | 13% |
| Student > Ph. D. Student | 18 | 10% |
| Other | 15 | 9% |
| Researcher | 15 | 9% |
| Other | 38 | 22% |
| Unknown | 36 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 75 | 43% |
| Nursing and Health Professions | 15 | 9% |
| Agricultural and Biological Sciences | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Other | 10 | 6% |
| Unknown | 47 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2018.
All research outputs
#2,474,685
of 25,490,562 outputs
Outputs from Critical Care
#2,154
of 6,572 outputs
Outputs of similar age
#24,211
of 241,231 outputs
Outputs of similar age from Critical Care
#23
of 167 outputs
Altmetric has tracked 25,490,562 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,572 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,231 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.